Navigation Links
Press Ganey Names Chief Sales and Marketing Officer
Date:5/21/2009

Al Vega Tapped to Lead Health Care Improvement Firm's Sales, Marketing Efforts

South Bend, Ind. (Vocus) -- Press Ganey Associates, Inc. today announced the addition of Al Vega as senior vice president and chief sales and marketing officer. Mr. Vega joins the company at a time of continued growth and will be responsible for driving sales and marketing efforts for the company. In particular, he will be responsible for the development, execution, and effectiveness of sales strategies, which in conjunction with marketing, will create demand for the company's products and programs to its target markets.

"I am extremely pleased to welcome Al to our team at Press Ganey," said Richard Siegrist, Press Ganey president and CEO. "His experience and innovation in the health care industry will be a great asset to the company as we are poised to grow our services and capabilities throughout the coming years."

Prior to joining Press Ganey, Al was with Focused Health Solutions, a leading provider of health population management services to employers and third-party administrators, where he led the company's client-facing sales, marketing, and acute management functions.

Previously, he was senior vice president of sales and corporate marketing at Solucient, a leading provider of benchmarking products and data analytic services for strategic planning, operational, clinical, and customer relationship management to the provider and pharmaceutical markets.

Al has also worked in senior leadership roles with Eclypsis Corporation, Carelinc Corporation, HealthVision, and Ameritech Health Connections.

Al holds a bachelor of arts in economics from the University of Maryland.

Press Ganey Associates, Inc.
For more than 2
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
2. Abbotts XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, Real World Patients in SPIRIT V Study
3. New mtvU & Associated Press Poll Shows How Stress, the Economy & Other Factors are Affecting College Students Mental Health
4. Press Ganey Names Chief Sales and Marketing Officer
5. Study Links Cancerous Tumors With Depression
6. New Study Reveals Wide Variations in Depression Diagnoses among Ethnic Groups
7. Protein that suppresses androgen receptors could improve prostate cancer diagnosis, treatment
8. National Press Club to Host NEWSMAKER Media Briefing on Cancer Policy
9. Depression Hits 1 in 13 American Adults
10. Study Shows NeuroStar TMS Therapy(R) Improved Key Elements of Cognition in Patients with Major Depressive Disorder
11. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Press Ganey Names Chief Sales and Marketing Officer
(Date:8/3/2015)... FL (PRWEB) , ... August 03, 2015 , ... ... to date of its industry-defining contract lifecycle management solution, as well as announced ... designed to increase the speed and ease of contract management tasks as well ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... the development of it’s new program “Designing Secure Healthcare Systems” This three-day, ... and technology leaders from healthcare organizations with access to the tactics, techniques and ...
(Date:8/3/2015)... ... ... A July 13 article from The Daily Mail titled "Jab That ... Can Last 'For Five Weeks'" discusses the use of stem cells to help ... harvesting stem cell-rich bone marrow from the hip, known as bone marrow stromal cells ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... insurance brokerage firm, announced today that Joe Williams has joined its growing California ... and delivering HUB's differentiated service model to his clients. Mr. Williams will be ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... management and investigative services, has introduced a new logo and comprehensive brand ... that improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. ...
Breaking Medicine News(10 mins):Health News:Novatus Unveils Milestone Software Release 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
... reflect results of new study , , FRIDAY, Jan. 18 (HealthDay ... American women carries a risk of serious blood clots that ... control pill, the U.S. Food and Drug Administration warned ... study that discovered the increased danger, the agency said it ...
... in Vegan Diet War, WASHINGTON, Jan. 18 ... the misleading Physicians Committee,for Responsible Medicine (PCRM) for ... which sued eight restaurant chains this week,over the ... been exposed,in Newsweek and The New York Times ...
... the United States Food and,Drug Administration (FDA) has ... cholesterol lowering medication also indicated for,improving glycemic control ... in,combination with metformin, sulfonylureas, or insulin, when these ... anti-diabetic agents., The ADA estimates that 20.8 ...
... Jan. 18 175 students from,the Academy of Columbus, ... the sixth annual Give Kids A Smile! Day state ... state kick-off will be held in the Atrium at ... from,The Ohio State University College of Dentistry, legislators and ...
... aggressive disease in 2 men taking the product , , ... product described as a dietary supplement appears to have ... two men, researchers report. , "There were things on ... components in the product that were not on the ...
... Part of Available Resources-, JACKSONVILLE, Fla., Jan. ... group of returning wounded veterans are the most ... has expanded,their ever-evolving battery of programs and services ... initiative., The Warriors to Work (WtoW) program ...
Cached Medicine News:Health News:FDA Warns Clot Risk Higher in Birth Control Patch Than Pill 2Health News:FDA Warns Clot Risk Higher in Birth Control Patch Than Pill 3Health News:Phony 'Physicians Committee' Suing Restaurants is Animal-Rights Trojan Horse, says CCF 2Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Statehouse Atrium to be Site for Children's Dental Access Event - Ohio Legislators to Mingle With Children and Dentists for This Free Care Event! 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 3Health News:Wounded Warrior Project (WWP) Expands Service Offerings for Injured Soldiers with the New 'Warriors to Work' Program 2
(Date:8/3/2015)... JUPITER, Fla. , Aug. 3, 2015 /PRNewswire/ ... announced initiation of its second clinical development program ... drug candidate, CL-H1T.  CL-H1T contains ... is being developed as a treatment for migraine ... "Many patients with migraine headaches ...
(Date:8/3/2015)... Israel , August 3, 2015 ... received the statistical analysis of results from a study which ... BVX-005 phase II trial which took place in 2012, provided ... exist at the time of the study- in particular the ... epidemic in the United States in ...
(Date:8/3/2015)... 3, 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... an exclusive licensing agreement to develop and commercialize multiple ... Limited, a holding company for premier antibody development and ... Under the terms of the agreement, Sorrento ... for the North American, European and Japanese market. Each ...
Breaking Medicine Technology:Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4
... YORK, April 9, 2008 Intra-Cellular Therapies, ... ongoing development,programs for ITI-007, the Company,s first-in-class ... and ITI-722,a low-dose formulation of ITI-007, which ... respectively. These new data demonstrate,ITI-007 has preclinical ...
... ... - Preliminary Phase I/II results to be presented in June at 2008 ... ... ), a clinical-stage biopharmaceutical company,focused on oncology, announced today that it has advanced CR011-vcMMAE, ...
Cached Medicine Technology:Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3CuraGen Advances CR011-vcMMAE into Phase II 2CuraGen Advances CR011-vcMMAE into Phase II 3CuraGen Advances CR011-vcMMAE into Phase II 4
Inquire...
Richardson Retractor...
A full, rounded look that adds greater dimension to the breast. Moderate base, with a higher profile than our Style 1600 implant....
... implant is an expanded porous polytetrafluoroethylene,material ... repair of the soft tissues of ... in sheets and shaped geometries with ... implant strands are packaged with and,without ...
Medicine Products: